Watch four AI models compete on clinical, financial, strategic, and image generation questions — then see where they disagree.
💊Should I start duloxetine 60mg for a 62yo with diabetic neuropathy and stage 3 CKD?LIVE
🔍
PolyLens™Bias Analysis
7/10
WHAT ONE AI HID
Grok recommended duloxetine without mentioning a single adverse event, hepatotoxicity warning, or renal dose adjustment. The other three models all flagged safety concerns.
Most biasedGrok
Most balancedClaude
PolyVerify™Citation Integrity
Γ£ô4 verifiedΓ£ù1 failed
FOLLOW THE MONEY
3 of 4 cited trials were Eli Lilly–sponsored. Only GPT's Evidence Skeptic flagged that enriched enrollment inflates NNT from 5 to ~8 in real-world populations.
Γ£ôGoldstein et al. 2005, Duloxetine for DPNP (Eli Lilly–sponsored)3/4
Γ£ôAAN Practice Guideline 2022, Painful Polyneuropathy3/4
🧬Synthesis
Final scoreboard
ACCDEPCREACT
👑ClaudeClinical Pharmacologist
9999
36/40
2GPTEvidence Skeptic
9888
33/40
3GeminiGuideline Synthesizer
8887
31/40
4GrokPatient-Centered Realist
7776
27/40
THE PLATFORM
Eight products. One subscription.
Every tool works together — scoring, verification, bias detection, image analysis, and evidence grading run automatically.
🏛️PolyVerge™Core
4 AIs compete on every question. Scored across accuracy, depth, creativity, and actionability. The arbiter synthesizes the best answer.
🔍PolyVerify™Pro
Cross-model citation verification. When 3 of 4 models cite the same source and it checks out in Semantic Scholar — that's a quorum.
🔬PolyLens™Free
6-dimension bias detection using a role-free pass. See exactly where models diverge on political framing, omissions, and source authority.
📋PolyReview™Pro
Medical study analysis with GRADE, CONSORT, Cochrane, and Newcastle-Ottawa. Four independent evidence evaluations.
💊PolyRx™Pro
Cross-model drug & treatment verification. Catches pharma bias by making rival AI models fight over clinical evidence.
🎨PolyVision™Live
4 AI image generators compete on one prompt. Vision-scored across 5 dimensions with visual bias detection by PolyLens™.
🏢PolyGuard™Enterprise
AI Governance-as-a-Service. Pipe your org's AI outputs through 4 independent models for bias auditing and compliance.
PolyVision sends your prompt to 4 image generators from 4 different companies — then scores and analyzes what they each chose to show you.
G
GPT Image 1.5
OpenAI
X
Grok Imagine
xAI
F
FLUX.2 Pro
Black Forest Labs
G
Gemini Image
Google
Prompt Fidelity
9/10
Omission Detection
8/10
Hallucination Flags
7/10
Artistic Quality
9/10
Text Accuracy
6/10
7/10
PolyLens™ Visual — Convergence bias detected
All 4 models defaulted to an East Asian night market for "a busy street food scene." None depicted African, South American, or Middle Eastern street food — revealing shared training data bias across all providers.
Everyone else gives you one model's opinion. We give you four.
Feature
PolyVerge
Others
AI models
4 models, 4 companies
1 model
Scoring
40-point rubric per model
None
Bias detection
6 dimensions (PolyLens™)
None
Citation verification
Cross-model + database
Self-reported
Evidence grading
GRADE / CONSORT / Cochrane / NOS
None
Drug verification
PolyRx™ pharma bias check
None
Dissent mode
AI argues against itself
None
Image generation
4 models + visual bias (PolyVision™)
None
Price
$9.99/mo Pro
$20+/mo per model
Perplexity's Model Council costs $200/month. PolyVerge Pro is $9.99/month — with scoring, bias detection, citation verification, evidence grading, and dissent mode.
Stop trusting one AI. Make them compete.
Free to start. No credit card required. Ask your first question in 10 seconds.
